A Tool to Distinguish Viral From Bacterial Pneumonia

Supplemental Digital Content is available in the text. Background: Establishing the etiology of community-acquired pneumonia (CAP) in children at admission is challenging. Most of the admitted children with CAP receive antibiotics. We aimed to build and validate a diagnostic tool combining clinical, analytical and radiographic features to differentiate viral from bacterial CAP, and among bacterial CAP, typical from atypical bacteria. Methods: Design—observational, multi-center, prospective cohort study was conducted in 2 phases. Settings: 24 secondary and tertiary hospitals in Spain. Patients—A total of 495 consecutive hospitalized children between 1 month and 16 years of age with CAP were enrolled. Interventions—A score with 2 sequential steps was built (training set, 70% patients, and validation set 30%). Step 1 differentiates between viral and bacterial CAP and step 2 between typical and atypical bacterial CAP. Optimal cutoff points were selected to maximize specificity setting a high sensitivity (80%). Weights of each variable were calculated with a multivariable logistic regression. Main outcome measures—Viral or bacterial etiology. Results: In total, 262 (53%) children (median age: 2 years, 52.3% male) had an etiologic diagnosis. In step 1, bacterial CAPs were classified with a sensitivity = 97%, a specificity = 48%, and a ROC’s area under the curve = 0.81. If a patient with CAP was classified as bacterial, he/she was assessed with step 2. Typical bacteria were classified with a sensitivity = 100%, a specificity = 64% and area under the curve = 0.90. We implemented the score into a mobile app named Pneumonia Etiology Predictor, freely available at usual app stores, that provides the probability of each etiology. Conclusions: This 2-steps tool can facilitate the physician’s decision to prescribe antibiotics without compromising patient safety.

[1]  O. Ruuskanen,et al.  Wheezing independently predicts viral infection in children with community‐acquired pneumonia , 2019, Pediatric pulmonology.

[2]  S. Madhi,et al.  Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study , 2019, The Lancet.

[3]  C. Blyth,et al.  Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children , 2019, BMC Pulmonary Medicine.

[4]  P. Joynt Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized with Pneumonia , 2018 .

[5]  S. Madhi,et al.  Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus–Associated Pneumonia Among Children Aged <5 Years in the PERCH Study , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  P. Vanhems,et al.  Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational Study , 2017, The American journal of tropical medicine and hygiene.

[7]  Anami R Patel,et al.  Community-acquired pneumonia requiring hospitalization among U.S. children. , 2015, The New England journal of medicine.

[8]  A. Gennery,et al.  Utility of inflammatory markers in predicting the aetiology of pneumonia in children. , 2014, Diagnostic microbiology and infectious disease.

[9]  A. Lindstrand,et al.  Clinical Utility of PCR for Common Viruses in Acute Respiratory Illness , 2014, Pediatrics.

[10]  A. Chang,et al.  Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. , 2015, The Cochrane database of systematic reviews.

[11]  F. Valent,et al.  Differentiation of bacterial and viral community‐acquired pneumonia in children , 2009, Pediatrics international : official journal of the Japan Pediatric Society.

[12]  J. Scott,et al.  The global epidemiology of childhood pneumonia 20 years on. , 2008, Bulletin of the World Health Organization.

[13]  R. Flood,et al.  The Utility of Serum C-Reactive Protein in Differentiating Bacterial from Nonbacterial Pneumonia in Children: A Meta-Analysis of 1230 Children , 2008, The Pediatric infectious disease journal.

[14]  J. Krishnan,et al.  Development and validation of a clinical prediction rule to distinguish bacterial from viral pneumonia in children , 2006, Pediatric pulmonology.

[15]  A. Bartelds,et al.  A Case-Control Study of Acute Respiratory Tract Infection in General Practice Patients in The Netherlands , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Carlin,et al.  Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. , 2005, Bulletin of the World Health Organization.

[17]  Robert E Black,et al.  WHO estimates of the causes of death in children , 2005, The Lancet.

[18]  E Svedström,et al.  Differentiation of bacterial and viral pneumonia in children , 2002, Thorax.

[19]  J. Coste,et al.  Procalcitonin in children admitted to hospital with community acquired pneumonia , 2001, Archives of disease in childhood.